Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001698258 | SCV000532372 | likely benign | not provided | 2019-12-03 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000560370 | SCV000646502 | likely benign | Colorectal cancer, susceptibility to, 10 | 2024-01-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000571443 | SCV000671013 | likely benign | Hereditary cancer-predisposing syndrome | 2016-07-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
KCCC/NGS Laboratory, |
RCV000560370 | SCV004016651 | likely benign | Colorectal cancer, susceptibility to, 10 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003897924 | SCV004710964 | likely benign | POLD1-related condition | 2022-12-09 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
True Health Diagnostics | RCV000571443 | SCV000805286 | likely benign | Hereditary cancer-predisposing syndrome | 2018-05-01 | no assertion criteria provided | clinical testing |